MONTERA, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 4.792
NA - Nord America 1.690
EU - Europa 713
SA - Sud America 212
AF - Africa 36
OC - Oceania 14
Totale 7.457
Nazione #
SG - Singapore 3.710
US - Stati Uniti d'America 1.607
CN - Cina 516
IT - Italia 316
HK - Hong Kong 294
BR - Brasile 142
GB - Regno Unito 118
FR - Francia 94
VN - Vietnam 90
IN - India 63
DE - Germania 62
CA - Canada 45
MX - Messico 27
AR - Argentina 26
NL - Olanda 22
CZ - Repubblica Ceca 21
BD - Bangladesh 19
TR - Turchia 15
AU - Australia 13
IQ - Iraq 13
ZA - Sudafrica 11
CL - Cile 10
EC - Ecuador 10
JP - Giappone 10
SA - Arabia Saudita 10
FI - Finlandia 8
ID - Indonesia 8
EE - Estonia 7
PH - Filippine 7
PL - Polonia 7
RU - Federazione Russa 7
SE - Svezia 7
UA - Ucraina 7
PY - Paraguay 6
AZ - Azerbaigian 5
AT - Austria 4
EG - Egitto 4
ES - Italia 4
NP - Nepal 4
PK - Pakistan 4
RS - Serbia 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CO - Colombia 3
DZ - Algeria 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AO - Angola 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
SV - El Salvador 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CU - Cuba 1
DJ - Gibuti 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
IR - Iran 1
KG - Kirghizistan 1
LR - Liberia 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RE - Reunion 1
RW - Ruanda 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 7.457
Città #
San Jose 486
Ashburn 435
Singapore 383
Hong Kong 289
Rome 236
Hefei 177
Beijing 146
Boardman 94
London 90
Santa Clara 86
Lauterbourg 75
Shanghai 57
Dallas 36
Ho Chi Minh City 34
Los Angeles 31
Munich 31
San Francisco 29
São Paulo 27
Brno 21
Council Bluffs 21
Montreal 20
Pune 19
Buffalo 18
Hanoi 18
Toronto 16
Washington 16
New York 14
Amsterdam 13
Milan 12
Seattle 12
Mexico City 11
Secaucus 10
Grumo Nevano 9
Brooklyn 8
Sorab 8
Tokyo 7
Warsaw 7
Canberra 6
Chicago 6
Coral Springs 6
Paris 6
Santiago 6
Boston 5
Dhaka 5
Frankfurt am Main 5
Johannesburg 5
Orem 5
Rio de Janeiro 5
Stockholm 5
Asunción 4
Catania 4
Da Nang 4
Guangzhou 4
Guayaquil 4
Naples 4
New Delhi 4
Poplar 4
Ribeirão Preto 4
Riyadh 4
Salt Lake City 4
Temecula 4
Turku 4
Baghdad 3
Baku 3
Cairo 3
Charlotte 3
Chennai 3
City of London 3
Cusano Milanino 3
Helsinki 3
Hyderabad 3
Jeddah 3
Karbala 3
Kirkuk 3
Kuwait City 3
Melbourne 3
Montevideo 3
Mysore 3
Nairobi 3
Newark 3
Oklahoma City 3
Quezon City 3
Quito 3
Sonoma 3
Taipei 3
Thái Bình 3
Ankara 2
Anápolis 2
Atlanta 2
Belgrade 2
Belo Horizonte 2
Bengaluru 2
Berlin 2
Brasília 2
Bratislava 2
Brusaporto 2
Buford 2
Calgary 2
Campinas 2
Can Tho 2
Totale 3.219
Nome #
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 253
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 241
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 241
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 237
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 231
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 222
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 220
Antiangiogenics and immunotherapies in cervical cancer: an update and future's view 212
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 209
Does HE4 have a role in the recurrence of ovarian cancer? 204
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 194
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 191
A critical review on HE4 performance in endometrial cancer: where are we now? 141
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 136
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 127
An ultra-miniinvasive treatment for stress urinary incontinence in complicated older patients 126
A new type of absorbable barbed suture for use in laparoscopic myomectomy 122
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 120
A gastrointestinal stromal tumor presenting as a pelvic mass: A case report 120
Bladder function after laparoscopic nerve-sparing radical hysterectomy 120
Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature 120
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 114
Aortic lymphadenectomy in cervical cancer: Anatomy, classification and technique 112
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 111
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 110
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 110
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 109
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 104
Pelvic-cutaneous fistula after retropubic vaginal tape placement 101
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 95
Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? 82
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 79
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 77
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 73
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 69
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 68
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 59
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 57
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 56
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 55
Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study 55
Tension-free vaginal tape versus transobturator suburethral tape: Five-year follow-up results of a prospective, randomised trial 54
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 54
Surgical primary treatment of stage IVA cervical cancer: A multicentre retrospective study 54
Ovarian cancer relapse: From the latest scientific evidence to the best practice 53
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 53
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 52
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 51
Sacral neuromodulation after stabilization of L2-S1 vertebrae with metallic fixation devices: is it feasible? 50
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study 49
Effectiveness of CO2 laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study 48
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 48
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 47
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 46
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 46
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial 45
Real-time infrared thermography for ureter detection during hysterectomy 45
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 44
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 44
Update on lymphadenectomy in early and advanced ovarian cancer 44
The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view 44
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study 44
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 43
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 42
Ten years of HPV vaccines: State of art and controversies 42
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 42
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 41
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 41
The role of macroplastique implantation in the management of occult urinary stress incontinence 41
Continuous wound infusion as a valid alternative to tap block for postoperative analgesia after abdominal hysterectomy: A randomized controlled trial 40
Hormone replacement therapy in cancer survivors: Utopia? 40
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 40
Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy? 39
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 39
Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer 37
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 37
Vaginectomy as treatment of isolated vaginal relapse (IVR) of gynecological neoplasms 37
Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study 36
Learning curves of a resident surgeon performing transobturator tape procedures for stress urinary incontinence 36
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer 36
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 35
The novel biomarker HE4 versus CA125 in detecting endometrial cancer: A case control prospective study 33
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 32
Surgical primary treatment of stage IVA cervical cancer: A multicenter retrospective study. 32
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 32
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 31
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers 31
Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up 30
Reply from Authors re: Elisabetta Costantini, Massimo Lazzeri. Elephants Can Remember. Eur Urol 2010;58: 678-9 29
Totale 7.492
Categoria #
all - tutte 43.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 9 0 0 0 0 4 1 4 0 113
2022/202345 0 1 1 0 1 1 10 2 2 3 16 8
2023/2024443 14 39 28 36 36 137 5 60 8 13 34 33
2024/20254.104 78 22 118 27 25 90 62 37 228 265 1.429 1.723
2025/20262.769 266 142 125 268 161 190 880 198 295 244 0 0
Totale 7.492